Batty K, Li M, Baron-Hay S. Pembrolizumab as adjuvant therapy in a patient with Lynch syndrome with synchronous mixed clear cell carcinoma of ovarian origin and endometroid endometrial carcinoma. BMJ Case Rep 2021;14.
PMID: 34772680